Simplex Trading, LLC Halozyme Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$36.46 - $44.03 $78,243 - $94,488	2,146 Added 64.27%	5,485 $209,000
Q2 2023 Aug 04, 2023	BUY	$30.28 - $38.74 $101,104 - $129,352	3,339 New	3,339 $120,000
Q3 2022 Nov 04, 2022	BUY	$38.53 - $51.78 $147,608 - $198,369	3,831 New	3,831 $151,000
Q2 2021 Aug 12, 2021	SELL	$38.84 - $51.31 $433,415 - $572,568	-11,159 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$39.51 - $51.45 $409,916 - $533,793	10,375 Added 1323.34%	11,159 $0
Q4 2020 Feb 02, 2021	SELL	$25.81 - $43.62 $834,772 - $1.41 Million	-32,343 Reduced 97.63%	784 $33,000
Q3 2020 Oct 14, 2020	BUY	$25.74 - $29.63 $852,688 - $981,553	33,127 New	33,127 $870,000
Q2 2020 Jul 13, 2020	SELL	$16.25 - $26.81 $163,020 - $268,957	-10,032 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$13.9 - $21.83 $139,444 - $218,998	10,032 New	10,032 $180,000
Q3 2019 Oct 15, 2019	SELL	$15.2 - $17.69 $137,879 - $160,465	-9,071 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$14.75 - $17.26 $7,242 - $8,474	-491 Reduced 5.13%	9,071 $155,000
Q1 2019 Apr 18, 2019	BUY	$13.94 - $17.58 $2,174 - $2,742	156 Added 1.66%	9,562 $0
Q4 2018 Jan 16, 2019	SELL	$13.33 - $18.66 $49,707 - $69,583	-3,729 Reduced 28.39%	9,406 $137,000
Q3 2018 Oct 23, 2018	BUY	$16.68 - $18.41 $90,372 - $99,745	5,418 Added 70.21%	13,135 $238,000
Q2 2018 Jul 30, 2018	BUY	$16.87 - $20.3 $23,483 - $28,257	1,392 Added 22.01%	7,717 $130,000
Q1 2018 Apr 26, 2018	SELL	$17.06 - $21.2 $81,069 - $100,742	-4,752 Reduced 42.9%	6,325 $123,000
Q4 2017 Jan 10, 2018	BUY	$16.75 - $20.8 $111,772 - $138,798	6,673 Added 151.52%	11,077 $224,000
Q3 2017 Oct 25, 2017	BUY	$11.76 - $17.4 $51,791 - $76,629	4,404	4,404 $76,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account